𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reply to receipt of adjuvant breast cancer therapy in minority women

✍ Scribed by Rachel A. Freedman; Nancy L. Keating

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
62 KB
Volume
118
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Completion of adjuvant radiation therapy
Completion of adjuvant radiation therapy among women with breast cancer
✍ Tomasz P. Srokowski; Shenying Fang; Zhigang Duan; Thomas A. Buchholz; Gabriel N. πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 98 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Optimal treatment for breast cancer often involves lengthy multimodality care including 5 to 6 weeks of radiotherapy, but few studies have evaluated adherence to radiotherapy outside the context of a therapeutic clinical trial. ## METHODS. Using a SEER‐Medicare databas

Cost-effectiveness of switching to exeme
Cost-effectiveness of switching to exemestane versus continued tamoxifen as adjuvant therapy for postmenopausal women with primary breast cancer
✍ Nancy A. Risebrough; Shailendra Verma; Maureen Trudeau; Nicole Mittmann πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 170 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Sequential tamoxifen/exemestane therapy reportedly improves disease‐free survival in women with primary breast cancer compared with continued tamoxifen therapy. The objective of the current study was to assess the cost‐effectiveness of switching to exemestane after 2 to